Phase IV Open Label Single Group One Year Study Of Home Self-injection With Sayana (Registered) Press In Adult Women Of Reproductive Age - A Pragmatic Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2017
At a glance
- Drugs Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Sep 2017 Status changed from not yet recruiting to recruiting.
- 03 Aug 2017 Planned initiation date changed from 1 Jul 2017 to 14 Aug 2017.
- 05 Jul 2017 Planned End Date changed from 19 Apr 2019 to 1 May 2019.